Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Vaisar

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|February 21, 2009
Thematic review series: proteomics. Proteomic analysis of lipid-protein complexesTomas Vaisar
Current Opinion in Lipidology|August 20, 2024
Quantification of high-density lipoprotein particle number by proton nuclear magnetic resonance: don't believe the numbersTomas Vaisar, Jay Heinecke
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2016
Isolating and Quantifying Plasma HDL Proteins by Sequential Density Gradient Ultracentrifugation and Targeted ProteomicsClark M Henderson, Tomas Vaisar, Andrew N Hoofnagle
Current Diabetes Reports|April 29, 2010
HDL lipids and insulin resistanceAndrew N Hoofnagle, Tomas Vaisar, Poulami Mitra, et al.
Journal of Lipid Research|May 13, 2009
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptideGeoffrey D Wool, Tomas Vaisar, Catherine A Reardon, et al.
Current Opinion in Lipidology|October 25, 2024
Distinct roles of size-defined HDL subpopulations in cardiovascular diseaseW Sean Davidson, Tomas Vaisar, Jay W Heinecke, et al.
Atherosclerosis|September 11, 2024
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart diseaseTomas Vaisar, Ilona Babenko, Katalin V Horvath, et al.
The Journal of Biological Chemistry|August 11, 2011
Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK)Edward Thorp, Tomas Vaisar, Manikandan Subramanian, et al.
Circulation Research|April 16, 2013
Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotypeWill S Driscoll, Tomas Vaisar, Jingjing Tang, et al.
Current Opinion in Molecular Therapeutics|June 16, 2006
Pathways for oxidation of high-density lipoprotein in human cardiovascular diseaseBaohai Shao, Michael N Oda, Tomas Vaisar, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|February 21, 2009
Thematic review series: proteomics. Proteomic analysis of lipid-protein complexesTomas Vaisar
Current Opinion in Lipidology|August 20, 2024
Quantification of high-density lipoprotein particle number by proton nuclear magnetic resonance: don't believe the numbersTomas Vaisar, Jay Heinecke
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2016
Isolating and Quantifying Plasma HDL Proteins by Sequential Density Gradient Ultracentrifugation and Targeted ProteomicsClark M Henderson, Tomas Vaisar, Andrew N Hoofnagle
Current Diabetes Reports|April 29, 2010
HDL lipids and insulin resistanceAndrew N Hoofnagle, Tomas Vaisar, Poulami Mitra, et al.
Journal of Lipid Research|May 13, 2009
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptideGeoffrey D Wool, Tomas Vaisar, Catherine A Reardon, et al.
Current Opinion in Lipidology|October 25, 2024
Distinct roles of size-defined HDL subpopulations in cardiovascular diseaseW Sean Davidson, Tomas Vaisar, Jay W Heinecke, et al.
Atherosclerosis|September 11, 2024
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart diseaseTomas Vaisar, Ilona Babenko, Katalin V Horvath, et al.
The Journal of Biological Chemistry|August 11, 2011
Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK)Edward Thorp, Tomas Vaisar, Manikandan Subramanian, et al.
Circulation Research|April 16, 2013
Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotypeWill S Driscoll, Tomas Vaisar, Jingjing Tang, et al.
Current Opinion in Molecular Therapeutics|June 16, 2006
Pathways for oxidation of high-density lipoprotein in human cardiovascular diseaseBaohai Shao, Michael N Oda, Tomas Vaisar, et al.
Pageof 10